看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | No | No |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Pfizer Inc. |
| Perrigo Company plc |
| Sandoz Group AG |
| Viatris Inc. |
| Teva Pharmaceutical Industries Limited |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 0Q1N | 0Y5E | 0SAN | 0A5V | 0LER | H5P | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 9% | -4% | 0% | -3% | -25% | 16% | ||
| Fiscal Year - 1 | 2% | 0% | 1% | 0% | -7% | 9% | ||
| Fiscal Year - 2 | 36% | -3% | 10% | 10% | -27% | 8% | ||
| Fiscal Year - 3 | 32% | -2% | 11% | -6% | 4% | 18% | ||
| Fiscal Year - 4 | 10% | 1% | 6% | -4% | -33% | 20% | ||
| Fiscal Year - 5 | 17% | 3% | NA | 0% | -7% | 26% | ||
| Average | 18% | -1% | 6% | 0% | -16% | 16% | ||
| Median | 14% | -1% | 6% | -2% | -16% | 17% | ||
| Benchmarks | Ticker | |||||||
| Pfizer Inc. | LSE:0Q1N | |||||||
| Perrigo Company plc | LSE:0Y5E | |||||||
| Sandoz Group AG | LSE:0SAN | |||||||
| Viatris Inc. | LSE:0A5V | |||||||
| Teva Pharmaceutical Industries Limited | LSE:0LER | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | 0Q1N | 0Y5E | 0SAN | 0A5V | 0LER | H5P | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Mar-25 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 62,464 | 4,373 | 10,384 | 14,739 | 16,544 | 3,127 | ||
| Fiscal Year | 63,627 | 4,373 | 10,384 | 14,739 | 16,544 | 3,127 | ||
| Fiscal Year - 1 | 59,554 | 4,656 | 9,979 | 15,427 | 15,846 | 2,875 | ||
| Fiscal Year - 2 | 101,175 | 4,452 | 9,306 | 16,263 | 14,925 | 2,517 | ||
| Fiscal Year - 3 | 81,288 | 4,139 | 9,678 | 17,886 | 15,878 | 2,553 | ||
| Fiscal Year - 4 | 41,651 | 4,088 | 9,658 | 11,946 | 16,659 | 2,341 | ||
| Fiscal Year - 5 | 40,905 | 3,870 | NA | 11,501 | 16,887 | 2,207 | ||
| Net Income | ||||||||
| Latest Twelve Months | 7,867 | (161) | 0 | (634) | (1,639) | 359 | ||
| Fiscal Year | 8,020 | (161) | 0 | (634) | (1,639) | 359 | ||
| Fiscal Year - 1 | 2,134 | (4) | 77 | 55 | (559) | 190 | ||
| Fiscal Year - 2 | 31,366 | (131) | 848 | 2,079 | (2,446) | 188 | ||
| Fiscal Year - 3 | 22,413 | (131) | 908 | (1,269) | 417 | 421 | ||
| Fiscal Year - 4 | 6,630 | 44 | 462 | (670) | (3,990) | 431 | ||
| Fiscal Year - 5 | 10,707 | 159 | NA | 17 | (999) | 486 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 221,095 | 10,809 | 19,430 | 47,686 | 43,479 | 4,680 | ||
| Latest Fiscal Quarter | NA | 9,648 | 19,907 | 41,501 | 39,326 | 5,133 | ||
| Fiscal Year | 213,396 | 9,648 | 19,907 | 41,501 | 39,326 | 5,133 | ||
| Fiscal Year - 1 | 226,501 | 10,809 | 19,430 | 47,686 | 43,479 | 4,680 | ||
| Fiscal Year - 2 | 197,205 | 11,017 | 17,557 | 50,022 | 44,011 | 4,471 | ||
| Fiscal Year - 3 | 181,476 | 10,426 | 17,542 | 54,843 | 47,666 | 4,372 | ||
| Fiscal Year - 4 | 154,229 | 11,488 | 17,946 | 61,553 | 50,640 | 4,135 | ||
| Fiscal Year - 5 | 167,594 | 11,301 | NA | 31,256 | 57,470 | 3,930 | ||
| Fiscal Year - 6 | 159,422 | 10,983 | NA | 32,735 | 60,683 | 3,497 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 92,282 | 4,768 | 8,645 | 20,467 | 7,506 | 2,198 | ||
| Latest Fiscal Quarter | 88,203 | 4,319 | 8,163 | 18,636 | 5,373 | 2,310 | ||
| Fiscal Year | 88,203 | 4,319 | 8,163 | 18,636 | 5,373 | 2,310 | ||
| Fiscal Year - 1 | 89,014 | 4,768 | 8,645 | 20,467 | 7,506 | 2,198 | ||
| Fiscal Year - 2 | 95,661 | 4,842 | 8,748 | 21,072 | 7,804 | 2,135 | ||
| Fiscal Year - 3 | 77,201 | 5,152 | 8,153 | 20,493 | 10,278 | 2,453 | ||
| Fiscal Year - 4 | 63,238 | 5,655 | 7,715 | 22,954 | 10,026 | 2,135 | ||
| Fiscal Year - 5 | 63,126 | 5,804 | NA | 11,884 | 13,972 | 2,117 | ||
| Fiscal Year - 6 | 63,388 | 5,668 | NA | 12,167 | 14,707 | 1,685 | ||